
Post Doctoral Fellow at @IdoAmitLab of immunu-genomics, @WeizmannScience. Mechanisms of tumor resistance, early detection, prediction & stratification in MM.
Israel
Joined June 2020
- Tweets20
- Following66
- Followers54
- Likes197
Thrilled to see our study published in @NatureGenet! We pushed the limits of scale to map multiple myeloma heterogeneity across 427 samples, integrating a double layer framework to decode the complexity of the disease. So proud to have led this research with the @IdoAmitLab.
Does scale limit what we can discover?
In our new @NatureGenet study, led by @MorZada3 & @Anna_Kurilovich, we built a 427-sample single-cell atlas of multiple myeloma across 341 individuals, linked to genetics and detailed clinical data 🧵 (1/15)
🔗 nature.com/articles/s41588-0…
Mor Zada retweeted
Finally new classification. Myeloma is not one disease #mmsm
Mor Zada retweeted
Online Now: Intratumoral plasma cells: More than a predictive marker of response to anti-PD-L1 treatment in lung cancer? dlvr.it/SKg1Bb
Mor Zada retweeted
Decade-long leukemia remissions with persistence of CD4+ CAR T cells | Nature
nature.com/articles/s41586-0…
Mor Zada retweeted
Myeloid antigen-presenting cell niches sustain antitumor T cells and license PD-1 blockade via CD28 costimulation dlvr.it/SFNgwY
Mor Zada retweeted
A pan-cancer signature for dysfunctional T cells dlvr.it/SFQscb
Mor Zada retweeted
Adoptive cell therapy with tumor-specific Th9 cells induces viral mimicry to eliminate antigen-loss-variant tumor cells dlvr.it/SFM4Np
Mor Zada retweeted
Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification dlvr.it/SFMyzG
Mor Zada retweeted
Outreach by transgender scientists has highlighted the importance of respecting authors’ privacy and autonomy in correcting the scientific record. Earlier this year, Science established a new name-change policy. Learn more: fcld.ly/3yu5tmv #TransAwarenessWeek
Mor Zada retweeted
1/ Excited to share how T cell therapies kill #leukemia!! multi-omics + new #computational #singlecell tools for longitudinal analysis 👉unexpected answer! cell.com/cell-reports/fullte…
*👏* @elhamazizi! 🙏 @dpeer Cathy Wu @MDAndersonNews @CPRITTexas @ColumbiaBME @sloan_kettering
Mor Zada retweeted
Tumor-associated macrophages (TAMs) support an immunosuppressive tumor microenvironment. Di Conza et al. uncover how ER stress responses pathways are engaged to orchestrate pro-tumorigenic features and survival in TAMs by tumor-derived lipids. rdcu.be/cAnmP @PCHo_Lab
Mor Zada retweeted
Happy to share a new preprint by the best collaborators on this planet and #theonlylabever. We show that "Anti-GM-CSF autoantibodies promote a pre-diseased state in Crohn's Disease" years before diagnosis.
medrxiv.org/content/10.1101/…
Read it, RT and let us know what you think!
Mor Zada retweeted
Amazonas state in Brazil has been hit hard by #COVID19 pandemic. New research shows it has lost 60.4% of the improvements in life expectancy at birth that had been accrued since 2000. Overall mortality in the country as whole is back to levels seen 20 yrs ago.
New estimates of life expectancy at birth and at age 65 years in Brazil reveal substantial declines as result of #COVID19, bringing mortality back to levels observed 20 or more years ago #SARSCoV2 nature.com/articles/s41591-0…
Mor Zada retweeted
We are very excited to share our new study identifying resistance pathways and therapeutic targets in relapsed multiple myeloma lead by @MorZada3, @MoonspiriTYin, and @AssafWeiner @WeizmannScience nature.com/articles/s41591-0… (1/14).





















